Tredaptive News
Most Popular Tredaptive Story
Merck's cholesterol drug wins European OK
Merck's cholesterol drug Tredaptive - known as Cordaptive in the U.S. -- has won European approval. The 1g/20mg modified-release tablets are a new lipid-modifying therapy for patients with... Read more...
Latest Headlines
- July 15, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
